Improvement in Subjective Sleep in Major Depressive Disorder With a Novel Antidepressant, Agomelatine

Abstract

Agomelatine showed similar antidepressant efficacy with earlier and greater efficacy in improving subjective sleep than venlafaxine in MDD patients.